Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Filings indexed 442 across all filing types
Latest filing 2021-04-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Capital Increase' (유상증자결정), which is a regulatory filing in South Korea. It details the decision to issue new shares, including the purpose, pricing, and allocation to third parties. Since it involves a change in capital structure and share issuance, it falls under the 'Share Issue/Capital Change' category.
2021-04-09 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the termination of a single sales and supply contract. It details the contract amount, the counterparty, the reason for termination, and the date of termination. Since this is a specific regulatory disclosure regarding a material business event (contract termination) that does not fit into categories like M&A, financial reports, or shareholder meetings, it is classified as a general regulatory filing.
2021-03-30 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the termination of a single sales and supply contract. It details the contract amount, the counterparty, the reason for termination, and the date of termination. Since this is a specific regulatory disclosure regarding a material business event (contract termination) that does not fit into categories like M&A, financial reports, or share transactions, it is classified as a general Regulatory Filing (RNS).
2021-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and the election of directors and auditors. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2021-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This is a standard corporate governance disclosure required by the Korea Exchange (KRX) when there are changes to the board of directors. Since the document specifically details changes in management/board composition, it falls under the 'Board/Management Information' category.
2021-03-25 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-03-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.